table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 hospitalized
COVID 19 hospitalizedCOVID-19 mild to moderate
antiandrogenic
progesterone Ghandehari
proxalutamide Cadegiani

2 studies excluded by filtering options 2

6371 McCoy, 2020 212excluded
7998 Cadegiani (female patients), 2021 213excludedhigh risk of bias

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons